Latest 10-Q quarterly reports

NASDAQ
MDB Capital Holdings, LLC filed its Q3 2026 Form 10-Q, revealing significant net losses and a substantial decrease in total assets, largely due to market value declines in investment securities and an impairment charge on an equity method investment.
NASDAQ
Inhibrx Biosciences, Inc. (INBX) filed its Q3 2026 Form 10-Q, detailing advancements in its oncology pipeline, including positive interim data for ozekibart and ordastobart, alongside financial updates and forward-looking statements.
NASDAQ
Idea Acquisition Corp. files its Q3 2026 Form 10-Q, detailing its financial position and operational activities as it continues its search for a business combination target.
NASDAQ
Vistagen Therapeutics reported reduced operating expenses and positive exploratory data for fasedienol, but faces substantial doubt about its ability to continue as a going concern and potential Nasdaq delisting.
NASDAQ
Space Asset Acquisition Corp. filed its quarterly report for the period ending September 30, 2026, detailing its financial position and operational status as a SPAC.
NASDAQ
Axiom Intelligence Acquisition Corp. 1 files its Q3 2026 Form 10-Q, detailing progress on its business combination with Terra Quantum and financial performance.
OQB
Bion Environmental Technologies, Inc. reported a net loss of $768,992 for the quarter ended September 30, 2026, with substantial liabilities and ongoing concerns about its ability to continue as a going concern.
NYSE
Bain Capital GSS Investment Corp. reports on its financial condition and operational activities for the quarter ended September 30, 2026, highlighting trust account management and administrative expenses while awaiting a business combination.
NASDAQ
Digital Asset Acquisition Corp. reports on its third-quarter 2026 financial status, highlighting investment income and ongoing efforts to secure a business combination before its liquidation deadline.
OID
ECA Marcellus Trust I reports a modest increase in distributable income for Q3 2026, driven by higher production volumes and improved realized prices, though overall proceeds remain subject to natural gas market fluctuations.
NYSE
Presidio Production Company reported increased revenues for Q3 2026 driven by higher commodity prices and recent acquisitions, though significant derivative losses led to a net loss.
NASDAQ
Royalty Management Holding Corporation reported increased revenues driven by its environmental services segment, but continued to incur net losses, highlighting ongoing operational challenges and reliance on specific contracts.
NASDAQ
Digimarc Corporation reported a 15% year-over-year revenue decrease for Q3 2026, with subscription revenue significantly impacted by contract expirations, while net losses widened.
NASDAQ
Trailblazer Acquisition Corp. reports on its financial status for the quarter ending September 30, 2026, highlighting interest income and ongoing efforts to identify a suitable business combination target.
NASDAQ
Blue Water Acquisition Corp. III reports on its financial condition and operational status for the quarter ending September 30, 2026, highlighting trust account performance and ongoing search for a business combination.
NASDAQ
Republic Digital Acquisition Company reports net income driven by investment gains on its trust account, with ongoing efforts to identify a business combination target.
NASDAQ
Armada Acquisition Corp. III reports on its third-quarter 2026 activities, highlighting progress in its search for a business combination target and managing operational expenses, with a significant business combination agreement signed post-quarter.
OQB
Adaptin Bio, Inc. filed its Q3 2026 Form 10-Q, detailing continued operating losses and significant concerns regarding its ability to continue as a going concern, alongside material weaknesses in internal controls.
OTC.Pink
MEDO Technologies, Inc. filed its Q3 2026 Form 10-Q, revealing significant operating losses and a precarious financial position that raises substantial doubt about its ability to continue as a going concern.
NASDAQ
Inflection Point Acquisition Corp. VI reports progress on its business combination with Quantum Space, with key agreements in place and a projected closing in Q4 2026, alongside significant financial assets.
NASDAQ
FB Bancorp, Inc. (FBL) filed its Q3 2026 10-Q, revealing a decrease in net income from continuing operations to $0.47 million from $1.02 million year-over-year, alongside a strategic focus on commercial lending and digital expansion.
NYSE
Owlet, Inc. reported a revenue decrease in Q3 2026, primarily due to a significant product recall impacting future sales and an estimated $13M-$18M cost, alongside ongoing efforts to address material weaknesses in internal controls.
AMEX
OptimumBank Holdings, Inc. announced robust financial results for the third quarter of 2026, showcasing substantial growth in assets, net interest income, and net income.
NASDAQ
BullFrog AI Holdings, Inc. reported Q3 2026 results, showing increased revenue but also significant net losses and continued concerns regarding its Nasdaq listing compliance and going concern status.
AMEX
Espey Mfg. & Electronics Corp. reported a revenue increase in its first fiscal quarter of 2027, though gross margins saw a slight decrease due to a shift in product mix towards lower-margin programs.
NYSE
National Presto Industries announced a substantial increase in net sales and net earnings for the third quarter ended October 4, 2026, primarily fueled by robust performance in its Defense segment.
NASDAQ
Propanc Biopharma, Inc. filed its Q3 2026 Form 10-Q, detailing substantial net losses, ongoing financing needs, and material weaknesses in internal controls, while also highlighting positive preclinical data for its lead asset, PRP.
YHD
AmperCap Acquisition Company reports net income for Q3 2026, primarily from investment gains on its trust account, while continuing its search for a business combination.
NASDAQ
K&F Growth Acquisition Corp. II reports on its third quarter ending September 30, 2026, detailing an extension of its business combination deadline to August 6, 2027, following significant shareholder redemptions.
OTC.Pink
Stemtech Corporation reported a sharp decline in net sales for Q3 2026, primarily due to a reduced distributor base, alongside continued net losses and a significant working capital deficit.